* Veracyte Inc VCYT.OQ reported a quarterly adjusted loss
of 12
cents per share for the quarter ended in September. The mean
expectation of eight analysts for the quarter was for a loss
of 25 cents per share.
* Revenue rose 25.2% to $75.59 million from a year ago;
analysts
expected $66.44 million.
* Veracyte Inc's reported EPS for the quarter was a loss
of 12
cents.
* The mean earnings estimate of analysts had fallen by
about 3% in
the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* Veracyte Inc shares had risen by 24.4% this quarter and
lost 49.9% so far this year.
* The company reported a quarterly loss of $8.72 million.
* Wall Street's median 12-month price target for Veracyte
Inc is
$30.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
2 at 09:38 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.25 -0.12 Beat
Jun. 30 2022 -0.22 -0.13 Beat
Mar. 31 2022 -0.24 -0.20 Beat
Dec. 31 2021 -0.16 -0.15 Beat